The global peptide therapeutics market is growing significantly due to the increasing prevalence of cardiovascular diseases and cancer, advances in peptide therapeutics manufacturing technology, and increasing healthcare expenditure. In addition, growing research and development activities along with a rich peptide therapeutics pipeline is expected to support the growth of the peptide therapeutics market. Patent expiration of several peptide drugs in the coming years will create ample opportunities for the global generic peptide therapeutics market to grow at a significant rate in the forecasted period. Peptides are made up of short chains of amino acid monomers. Peptide therapeutics have applications in several indications such as cancer, central nervous system disorders, respiratory disorders, and cardiovascular diseases; this is due to high selectivity, efficacy and safety of peptides.
Request for report sample at: https://www.psmarketresearch.com/market-analysis/peptide-therapeutics-market/report-sample
The advanced research and development facilities and new peptide developments by the pharmaceutical companies are propelling the demand for cost effective peptide therapeutics. However, production of peptides in a large scale with the increasing complexities of peptides is a major challenge for the global peptide therapeutics market. Development of multifunctional peptides and increasing number of collaboration for the development of peptide conjugates are trends in the global peptide therapeutics market.
Geographically, North America will be leading the global peptide therapeutics market in the coming years due to high prevalence of chronic diseases, high healthcare expenditure, and high research and development activities. In addition, advancements in the peptide manufacturing technology and rich peptide therapeutics pipeline are fueling the growth of peptide therapeutics market in North America region.
Browse full report at: https://www.psmarketresearch.com/market-analysis/peptide-therapeutics-market
Asia-Pacific is the fastest growing region in the global peptide therapeutics market. The major reasons for the fastest growth in the region are growing research and development activities, increasing prevalence of cancer and cardiovascular diseases, and increasing healthcare expenditure. Moreover, the peptide therapeutics market is growing rapidly due to the high generic drug market potential in the emerging economies, such as India and China.
Some of the major players operating in the global peptide therapeutics market are, Sanofi, Teva Pharmaceutical Industries Ltd., Novartis AG, Ipsen S.A., AstraZeneca plc, Amgen Inc., Eli Lilly and Company, Lonza Group Ltd., Merck & Co. Inc., Novo Nordisk A/S, F. Hoffmann-La Roche AG, Bachem Holding AG, PolyPeptide Group, and CordenPharma International GmbH.
About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Toll-free: +1-888-778-7886 (USA/Canada)
Email: [email protected]